• Je něco špatně v tomto záznamu ?

Activation of murine RNase L by isopolar 2'-phosphonate analogues of 2',5' oligoadenylates

Pav O., Protivinska E., Pressova M., Collinsova M., Jiracek J., Snasel J., Masojidkova M., Budesinsky M., Rosenberg I.

. 2006 ; 49 (13) : 3955-3962.

Jazyk angličtina Země Spojené státy americké

Typ dokumentu techniky in vitro

Perzistentní odkaz   https://www.medvik.cz/link/bmc07522375

To determine the influence of methylene group insertion in the internucleotide linkage on the binding process of 2',5'-oligoadenylates to RNase L, a series of 2'-phosphonate-modified trimers and tetramers were synthesized from appropriate monomeric units and evaluated for their ability to bind to murine RNase L. Tetramers pAAXA modified by ribo-, arabino-, or xylo-2'-phosphonate unit X in the third position were capable of binding to RNase L in nanomolar concentrations. The replacement of the first residue (pXAAA), or both the first and the third residues (pXAXA), was also tolerated by the enzyme. In contrast, in all cases, the replacement of the second residue (pAXAA) resulted in the significant decrease of binding ability. Additionally, no more than two phosphonate modifications in the tetramer were allowed to retain the binding affinity to the enzyme. Although all three tetramers pAAXA were found to be potent enzyme binders, only tetramers modified by ribo- and xylo-2'-phosphonate unit X activated the RNase L-catalyzed cleavage of the RNA substrate. Surprisingly, tetramer pAAXA, modified by arabino-2'-phosphonate unit X, did not activate the enzyme and can be considered a potent antagonist. In comparison with their natural counterpart, the phosphonate analogues of the pA4 exhibit superior resistance toward nucleases present in the murine spleen homogenate.

000      
00000naa 2200000 a 4500
001      
bmc07522375
003      
CZ-PrNML
005      
20130204145925.0
008      
090430s2006 xxu e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Páv, Ondřej $7 xx0093068
245    10
$a Activation of murine RNase L by isopolar 2'-phosphonate analogues of 2',5' oligoadenylates / $c Pav O., Protivinska E., Pressova M., Collinsova M., Jiracek J., Snasel J., Masojidkova M., Budesinsky M., Rosenberg I.
314    __
$a Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, 166 10 Prague 6, Czech Republic
520    9_
$a To determine the influence of methylene group insertion in the internucleotide linkage on the binding process of 2',5'-oligoadenylates to RNase L, a series of 2'-phosphonate-modified trimers and tetramers were synthesized from appropriate monomeric units and evaluated for their ability to bind to murine RNase L. Tetramers pAAXA modified by ribo-, arabino-, or xylo-2'-phosphonate unit X in the third position were capable of binding to RNase L in nanomolar concentrations. The replacement of the first residue (pXAAA), or both the first and the third residues (pXAXA), was also tolerated by the enzyme. In contrast, in all cases, the replacement of the second residue (pAXAA) resulted in the significant decrease of binding ability. Additionally, no more than two phosphonate modifications in the tetramer were allowed to retain the binding affinity to the enzyme. Although all three tetramers pAAXA were found to be potent enzyme binders, only tetramers modified by ribo- and xylo-2'-phosphonate unit X activated the RNase L-catalyzed cleavage of the RNA substrate. Surprisingly, tetramer pAAXA, modified by arabino-2'-phosphonate unit X, did not activate the enzyme and can be considered a potent antagonist. In comparison with their natural counterpart, the phosphonate analogues of the pA4 exhibit superior resistance toward nucleases present in the murine spleen homogenate.
650    _2
$a financování organizované $7 D005381
650    _2
$a adeninnukleotidy $x farmakologie $x chemická syntéza $x chemie $7 D000227
650    _2
$a zvířata $7 D000818
650    _2
$a endoribonukleasy $x metabolismus $7 D004722
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední BALB C $7 D008807
650    _2
$a oligoribonukleotidy $x farmakologie $x chemická syntéza $x chemie $7 D009843
650    _2
$a organofosfonáty $x farmakologie $x chemická syntéza $x chemie $7 D063065
650    _2
$a vazba proteinů $7 D011485
650    _2
$a slezina $x enzymologie $7 D013154
650    _2
$a stereoizomerie $7 D013237
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a techniky in vitro $7 D066298
700    1_
$a Protivínská, Eva $7 xx0110455
700    1_
$a Pressová, Martina $7 xx0128417
700    1_
$a Collinsová, Michaela $7 xx0110429
700    1_
$a Jiráček, Jiří, $d 1965- $7 xx0098873
700    1_
$a Snášel, Jan $7 xx0128983
700    1_
$a Masojídková, Milena $7 xx0128761
700    1_
$a Buděšínský, Miloš, $d 1944- $7 jn20010309100
700    1_
$a Rosenberg, Ivan, $d 1948- $7 xx0086095
773    0_
$w MED00010049 $t Journal of medicinal chemistry $g Roč. 49, č. 13 (2006), s. 3955-3962 $x 0022-2623
910    __
$a ABA008 $b x $y 9
990    __
$a 20090310084605 $b ABA008
991    __
$a 20120718203818 $b ABA008
999    __
$a ok $b bmc $g 647128 $s 500078
BAS    __
$a 3
BMC    __
$a 2006 $b 49 $c 13 $d 3955-3962 $i 0022-2623 $m Journal of medicinal chemistry $x MED00010049
LZP    __
$a 2009-B3/ipme

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...